XM does not provide services to residents of the United States of America.
S
S

SmithsGroup

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Argenx, Glencore, Volvo Car

EUROPE RESEARCH ROUNDUP- Argenx, Glencore, Volvo Car Aug 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Argenx, Glencore and Volvo Car, on Friday. HIGHLIGHTS * Argenx SE ARGX.BR : JP Morgan raises target price to EUR 570 from EUR 470 * Glencore GLEN.L : Morgan Stanley cuts target price to 470p from 480p * Rockwool A/S ROCKb.CO : Morgan Stanley raises PT to DKK 3023 from DKK 2664 * Swiss Re AG SRENH.S : RBC raises target price t
B
G
H
K
S
S
S
U
E
S
S

UK's Senior interim profit rises as Airbus contracts help mitigate Boeing concerns

UPDATE 2-UK's Senior interim profit rises as Airbus contracts help mitigate Boeing concerns H1 profit up 10% Sees mitigating lower Boeing sales in FY Declares interim dividend of 0.75p Rewrites with quotes from CEO call on Airbus, analysts comments, shares By Prerna Bedi Aug 5 (Reuters) - British engineering firm Senior Plc SNR.L posted a 10% rise in first-half profit on Monday as new and extended contracts with Airbus AIR.PA offset production issues with the Boeing BA.N 737 MAX.
A
B
B
S
R
S

Euronext, Pearson, Saint-Gobain

EUROPE RESEARCH ROUNDUP- Euronext, Pearson, Saint-Gobain July 30 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Euronext, Pearson and Saint-Gobain on Tuesday. HIGHLIGHTS * Adyen NV ADYEN.AS : HSBC cuts target price to EUR 1600 from EUR 1900 * Deutsche Boerse AG DB1Gn.DE : JP Morgan raises target price to EUR 198 from EUR 194 * Euronext NV ENX.PA : JP Morgan cuts target price to EUR 107 from EUR 108 * Pearson PSON.L : JP Morgan cut
A
C
C
D
D
E
E
H
H
L
L
P
P
P
R
S
S
S
A
D
J
S

Smiths Group Sells 1.2m Shares In Icu Medical

BRIEF-Smiths Group Sells 1.2m Shares In Icu Medical July 17 (Reuters) - Smiths Group PLC SMIN.L : SMITHS GROUP: SMITHS GROUP PLC SELLS 1.2M SHARES IN ICU MEDICAL INC SMITHS GROUP: SMITHS WILL RECEIVE NET PROCEEDS OF C.$152M (£117M) FROM SALE Source text for Eikon: ID:nRSQ6676Wa Further company coverage: SMIN.L
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.